John A. Orwin

Insider Reports History

Location
Redwood City, CA
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John A. Orwin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. Director Common Stock 35,375 $648,423 $18.33 15 May 2025 Direct
ANAPTYSBIO, INC Director Common Stock 10,665 $215,646 $20.22 15 Sep 2025 Direct
ANAPTYSBIO, INC Director Restricted Stock Unit 6,000 $92,259 $15.30 06 Jan 2026 Direct
Atreca, Inc. PRESIDENT & CEO, Director Class A Common Stock 77,541 $29,047 $0.3746 11 Apr 2024 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19,500 15 May 2025 Direct
ANAPTYSBIO, INC Director Stock Option (right to buy) 8,250 06 Jan 2026 Direct
Atreca, Inc. PRESIDENT & CEO, Director Series A Junior Preferred Stock 1 11 Apr 2024 Direct
CARGO Therapeutics, Inc. Director Stock Option (Right to Buy) 0 19 Aug 2025 Direct
Seagen Inc. Director Common Stock 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Restricted Stock Units 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Director Stock Options (Right to Buy) 0 14 Dec 2023 Direct

Insider Reports Filed by John A. Orwin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANAB ANAPTYSBIO, INC 06 Jan 2026 2 $0 4 Director 08 Jan 2026, 16:02
ANAB ANAPTYSBIO, INC 15 Sep 2025 2 $0 4 Director 17 Sep 2025, 16:02
CRGX CARGO Therapeutics, Inc. 19 Aug 2025 2 $0 4 Director 19 Aug 2025, 16:43
CRGX CARGO Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 20 Jun 2025, 17:36
ANAB ANAPTYSBIO, INC 15 Jun 2025 2 $0 4 Director 17 Jun 2025, 18:31
TVTX Travere Therapeutics, Inc. 15 May 2025 2 $0 4 Director 16 May 2025, 19:00
ANAB ANAPTYSBIO, INC 07 Jan 2025 2 $0 4 Director 07 Jan 2025, 17:29
ANAB ANAPTYSBIO, INC 15 Sep 2024 2 $0 4 Director 17 Sep 2024, 18:45
ANAB ANAPTYSBIO, INC 15 Jun 2024 2 $0 4 Director 18 Jun 2024, 20:15
CRGX CARGO Therapeutics, Inc. 04 Jun 2024 1 $0 4 Director 06 Jun 2024, 16:28
TVTX Travere Therapeutics, Inc. 08 May 2024 2 $0 4 Director 10 May 2024, 16:06
/report/000141588924011059-orwin-john-a-2024-04-11 Atreca, Inc. 11 Apr 2024 1 +$0.01 4 PRESIDENT & CEO, Director 17 Apr 2024, 19:36
ANAB ANAPTYSBIO, INC 03 Jan 2024 2 $0 4 Director 05 Jan 2024, 16:57
/report/000095017023070863-orwin-john-a-2023-12-14 Seagen Inc. 14 Dec 2023 11 -$6,641,687 4 Director 15 Dec 2023, 18:10
CRGX CARGO Therapeutics, Inc. 09 Nov 2023 1 $0 4 Director 13 Nov 2023, 18:48
CRGX CARGO Therapeutics, Inc. 09 Nov 2023 0 $0 3 Director 09 Nov 2023, 17:02
ANAB ANAPTYSBIO, INC 15 Sep 2023 4 $0 4 Director 18 Sep 2023, 18:11
ANAB ANAPTYSBIO, INC 15 Sep 2023 0 $0 3 Director 18 Sep 2023, 18:09
/report/000141588924010243-orwin-john-a-2023-09-01 Atreca, Inc. 01 Sep 2023 1 -$8,597 4 PRESIDENT & CEO, Director 03 Apr 2024, 21:37
/report/000120331123000061-orwin-john-a-2023-05-31 Seagen Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 18:21
TVTX Travere Therapeutics, Inc. 17 May 2023 2 $0 4 Director 19 May 2023, 16:05
/report/000120919123008958-orwin-john-a-2023-02-09 Atreca, Inc. 09 Feb 2023 1 $0 4 President & CEO, Director 13 Feb 2023, 20:00
/report/000120919122050778-orwin-john-a-2022-09-02 Atreca, Inc. 02 Sep 2022 1 -$37,116 4 President & CEO, Director 20 Sep 2022, 18:12
/report/000120919122037114-orwin-john-a-2022-06-13 Atreca, Inc. 13 Jun 2022 8 $0 4 President & CEO, Director 15 Jun 2022, 19:15
/report/000089924322018465-orwin-john-a-2022-05-13 Seagen Inc. 13 May 2022 2 $0 4 Director 17 May 2022, 19:33
TVTX Travere Therapeutics, Inc. 11 May 2022 2 $0 4 Director 12 May 2022, 20:30
/report/000120919121071425-orwin-john-a-2021-12-23 Atreca, Inc. 23 Dec 2021 1 $0 4 President & CEO, Director 28 Dec 2021, 17:50
/report/000120919121055809-orwin-john-a-2021-09-09 Atreca, Inc. 09 Sep 2021 1 $0 4 President & CEO, Director 13 Sep 2021, 21:46
TVTX Travere Therapeutics, Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 21:17
/report/000120331121000032-orwin-john-a-2021-05-14 Seagen Inc. 14 May 2021 2 $0 4 Director 18 May 2021, 19:27